[Aminoglycosides should still be used in empirical sepsis treatment]

Tidsskr Nor Laegeforen. 2013 May 28;133(10):1054-5. doi: 10.4045/tidsskr.13.0213.

[Article in Norwegian]

Authors

Paul Christoffer Lindemann¹, Bjørg C Haldorsen, Ingrid Smith, Haakon Sjursen, Haima Mylvaganam

Affiliation

¹ Klinisk institutt 2, Medisinskodontologisk fakultet, Universitetet i Bergen, Norway. paul.lindemann@gades.uib.no

PMID: 23712163
DOI: 10.4045/tidsskr.13.0213

No abstract available

MeSH terms

Aminoglycosides / adverse effects
Aminoglycosides / therapeutic use*
Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / therapeutic use*
Drug Resistance, Bacterial
Humans
Sepsis / drug therapy*

Substances

Aminoglycosides
Anti-Bacterial Agents